These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15567318)

  • 41. Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles.
    Tomoda K; Ohkoshi T; Kawai Y; Nishiwaki M; Nakajima T; Makino K
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):138-44. PubMed ID: 17890065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A study on the targeting collect character of ferromagnetic drug carrier particles in microvasculature].
    Li X; Guo P; Chen Y; Xiong P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):533-7. PubMed ID: 20649013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
    Sher P; Ingavle G; Ponrathnam S; Pawar AP
    Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dry powder inhaler formulation.
    Telko MJ; Hickey AJ
    Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alginate and chitosan particles as drug delivery system for cell therapy.
    Ciofani G; Raffa V; Menciassi A; Dario P
    Biomed Microdevices; 2008 Apr; 10(2):131-40. PubMed ID: 17874301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles.
    Tomoda K; Ohkoshi T; Nakajima T; Makino K
    Colloids Surf B Biointerfaces; 2008 Jun; 64(1):70-6. PubMed ID: 18343097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
    Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A
    J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of nano drug carriers towards optimum release rate.
    Ng EY; Ng WK
    J Med Eng Technol; 2007; 31(4):243-52. PubMed ID: 17566928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dexamethasone acetate encapsulation into Trojan particles.
    Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
    J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation.
    Handoko A; Ian L; Peter SJ
    Eur J Pharm Sci; 2009 Feb; 36(2-3):265-74. PubMed ID: 18996188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
    Rosenblatt KM; Bunjes H
    Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Turbulent Resuspension of Small Nondeformable Particles.
    Lazaridis M; Drossinos Y; Georgopoulos PG
    J Colloid Interface Sci; 1998 Aug; 204(1):24-32. PubMed ID: 9665763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of a sieve classification method for characterization of low-dose interactive mixtures.
    Bredenberg S; Dahlgren A; Mattsson S
    Pharm Dev Technol; 2013; 18(6):1366-71. PubMed ID: 22998104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dry mixing transformed micro-particles of a drug from a highly crystalline to a highly amorphous state.
    Höckerfelt MH; Nyström C; Alderborn G
    Pharm Dev Technol; 2009; 14(3):233-9. PubMed ID: 19519178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug content effects on the dispersion performance of adhesive mixtures for inhalation.
    Grasmeijer F; Hagedoorn P; Frijlink HW; de Boer AH
    PLoS One; 2013; 8(8):e71339. PubMed ID: 23967195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of particle size and concentration on the adhesive characteristics of a model drug-carrier interactive system.
    Kulvanich P; Stewart PJ
    J Pharm Pharmacol; 1987 Sep; 39(9):673-8. PubMed ID: 2890731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Influence of Interfacial Structuring on Gibbsite Interactions in Synthetic Bayer Liquors.
    Addai-Mensah J; Ralston J
    J Colloid Interface Sci; 1999 Jul; 215(1):124-130. PubMed ID: 10362481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing.
    de Villiers MM; Van der Watt JG
    Pharm Res; 1994 Nov; 11(11):1557-61. PubMed ID: 7870671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.